vvincii we show the working

← Health care

ARDT

Ardent Health

Health care · fiscal year ending 2022-12-31

Through the investors’ lenses

Each of these investors has said in public what they look at before buying. Click a name to see how this company measures up — a tick where it passes one of their tests, a cross where it does not.

Warren Buffett 2/3
MeasureARDTChecked against
Owner earnings$175.97mpositive
Return on equity18.2%median 11.7%
Debt to equitymedian 0.79x
Operating margin6.1%median 15.0%

Passes 2 of 3. To be clear: Warren Buffett has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Terry Smith 0/2
MeasureARDTChecked against
Return on capital employedmedian 10.1%
Cash conversion-0.20xmedian 1.78x
Operating margin6.1%median 15.0%
Debt to equitymedian 0.79x

Passes 0 of 2. To be clear: Terry Smith has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Charlie Munger 1/2
MeasureARDTChecked against
Return on capital employedmedian 10.1%
Return on equity18.2%median 11.7%
Operating margin6.1%median 15.0%

Passes 1 of 2. To be clear: Charlie Munger has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Chuck Akre 1/2
MeasureARDTChecked against
Return on equity18.2%median 11.7%
Debt to equitymedian 0.79x
Cash conversion-0.20xmedian 1.78x

Passes 1 of 2. To be clear: Chuck Akre has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Philip Fisher 0/2
MeasureARDTChecked against
Operating margin6.1%median 15.0%
Net margin3.7%median 10.2%
Return on capital employedmedian 10.1%

Passes 0 of 2. To be clear: Philip Fisher has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Peter Lynch 0/1
MeasureARDTChecked against
Debt to equitymedian 0.79x
Net margin3.7%median 10.2%

Passes 0 of 1. To be clear: Peter Lynch has never said anything about Ardent Health. These are the company’s own figures put through the tests he described. What he looks at, and why →

Last usable year: 2022-12-31 — 44 months ago. Nothing filed since gives the figures a payout ratio needs. For a company that once paid, that usually means it stopped.
BasisPayoutWhy
GAAP earnings92.4%
why
The figure most screeners publish.
Operating cash flownegative
why
Operations consumed $38.4m of cash.
Free cash flownegative
why
OCF fell $189m short of capex — the dividend was not funded from free cash flow.
Nothing is marked as applying, deliberately. The basis that governs here is free cash flow, and this year it yields no ratio at all. The figure above is shown for completeness; treating it as the answer is the substitution this page exists to prevent.

The arithmetic

Where the figures came from

All public at sec.gov — you should not have to take our word for it.

Caveats on this company


Computed straight from SEC XBRL. A number that looks wrong to you is more useful to us than agreement — tell us.

Also on: when it files.

When this changes

Every figure above is recomputed whenever Ardent Health files. The monthly letter carries what filed, what moved, and one finding computed across every company here.

Get the letter →